Generate a tailored SOP for Dr. Angela Cenci Nilsson. Improve your application with a focused, well-structured draft.
Angela Cenci Nilsson leads the research group 'Basal Ganglia Pathophysiology' at Lund University, focusing on investigating the molecular and cellular dysfunctions within the cortico-basal ganglia network related to Parkinson's disease (PD). Her translational research aims to understand fundamental disease mechanisms and to evaluate new treatment options for PD patients based on experimental models. She has gained international recognition for her work on rodent models of L-DOPA-induced dyskinesia (LID), which are now considered essential tools for studying the pathophysiological mechanisms in this area. Cenci Nilsson has explored the role of non-dopaminergic transmitter systems in PD and has identified treatment principles currently being investigated in clinical trials, such as negative allosteric modulators and selective agonists. In addition, her ongoing collaborative projects involve developing digital technologies and machine learning algorithms to enhance the translational studies of movement abnormalities associated with basal ganglia diseases.
Lund University • Lund, Sweden
Lead the research group focused on Basal Ganglia Pathophysiology.
Includes Master of Science in Politics and Society of the Contemporary Middle East and European Affairs.